DavidFitzgeraldArcherMD

Obstetrics & Gynecology • Norfolk, VA

Reproductive Endocrinology & Infertility

Professor, Obstetrics & Gynecology, Eastern Virginia Medical School

Join to view full profile

Are you Dr. Archer?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 31 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
601 Colley Ave
Norfolk, VA 23507
Phone+1 757-446-7100

Fax+1 757-446-7455
Is this information wrong?

Summary

Dr. David Archer, MD is an obstetrician/gynecologist in Norfolk, Virginia. He is currently licensed to practice medicine in Virginia and Pennsylvania. He is affiliated with Sentara Norfolk General Hospital and is a Professor at Eastern Virginia Medical School.

Education & Training

University of Louisville School of MedicineResidency, Obstetrics and Gynecology, 1963 - 1966
University of Louisville School of MedicineResidency, Obstetrics and Gynecology, 1961 - 1961
University of Louisville School of MedicineInternship, Transitional Year, 1960 - 1961
University of Louisville School of MedicineClass of 1960

Certifications & Licensure

VA State Medical License 1987 - 2024
PA State Medical License 1967 - 2014
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Reproductive Endocrinology/Infertility

Awards, Honors, & Recognition

Fellow (FACOG) American Congress of Obstetricians and Gynecologists

Clinical Trials

Norplant and Irregular Bleeding/Spotting Start of enrollment: 2003 Feb 01
Unknown status
Phase 4
Contraceptive Effectiveness and Safety of the SILCS Diaphragm Start of enrollment: 2008 Jan 01
Completed
Phase 2, Phase 3
Residence Time of Biomarkers of Semen Exposure Start of enrollment: 2008 Dec 01
Completed
PK of Depo SubQ Injected in the Upper Arm Start of enrollment: 2010 May 01
Completed
Not Applicable
DHEA Against Vaginal Atrophy - Safety Study of 12 Months Start of enrollment: 2010 Dec 01
Completed
Phase 3
DHEA Against Vaginal Atrophy - 3-Month Efficacy Study Start of enrollment: 2010 Dec 01
Completed
Phase 3
Dehydroepiandrosterone (DHEA) Against Vaginal Atrophy Start of enrollment: 2011 Jun 01
Completed
Phase 3
Topical DHEA Against Vaginal Atrophy Start of enrollment: 2007 Jun 01
Completed
Phase 3
Efficacy Study of Two Continuous Regimens of Oral Daily 5 mg or 10 mg of Ulipristal Acetate (UPA), Versus a Dose of 5.0mg UPA for 24/4 Days Start of enrollment: 2014 Mar 01
Completed
Phase 2
Effect of Oral Estradiol and Progesterone Therapy on Vaginal Cytokines in Postmenopausal Women Start of enrollment: 2015 Dec 01
Completed
Phase 3
Effect of Intravaginal Prasterone on Symptoms of VVA in Women Under Treatment With an Aromatase Inhibitor for Breast Cancer Start of enrollment: 2018 Nov 06
Withdrawn
Phase 3
Join now to see all

Publications & Presentations

PubMed

Comparison of estrogenic components used for hormonal contraception.
Frank Z Stanczyk, Sharon A Winer, Jean-Michel Foidart, David F Archer> ;Contraception. 2024 Feb 1
1 citations
The efficacy, safety, and tolerability of an estrogen-free oral contraceptive drospirenone 4 mg (24/4-day regimen) in obese users.
Mitchell D Creinin, Alicyoy Angulo, Enrico Colli, David F Archer> ;Contraception. 2023 Dec 1
1 citations
Biosynthesis of estetrol in human pregnancy: Potential pathways.
Frank Z Stanczyk, David F Archer> ;The Journal of Steroid Biochemistry and Molecular Biology. 2023 Sep 1
Satisfaction with a Segesterone Acetate and Ethinyl Estradiol Contraceptive Vaginal System Among Recent Oral Contraceptive or Hormonal Contraceptive Vaginal Ring Users.
Jeffrey T Jensen, David F Archer, Carolyn L Westhoff, Anita L Nelson, Shelli Graham, Brian Bernick> ;Journal of Women's Health. 2023 Jul 1
Oral estradiol/micronized progesterone may be associated with lower risk of venous thromboembolism compared with conjugated equine estrogens/medroxyprogesterone acetat...
Nick Panay, Rossella E Nappi, Petra Stute, Santiago Palacios, Tomasz Paszkowski, Risa Kagan, David F Archer, Julie Héroux, Mitra Boolell> ;Maturitas. 2023 Jun 1
6 citations
Tolerability and safety of the estetrol/drospirenone combined oral contraceptive: Pooled analysis of two multicenter, open-label phase 3 trials.
Melissa J Chen, Jeffrey T Jensen, Sharon L Achilles, János Zatik, Steven Weyers, Terhi Piltonen, Larisa Suturina, Inna Apolikhina, Celine Bouchard, David F Archer, Mau...> ;Contraception. 2022 Dec 1
17 citations
Linzagolix with and without hormonal add-back therapy for the treatment of symptomatic uterine fibroids: two randomised, placebo-controlled, phase 3 trials.
Jacques Donnez, Hugh S Taylor, Elizabeth A Stewart, Linda Bradley, Erica Marsh, David Archer, Ayman Al-Hendy, Felice Petraglia, Nelson Watts, Jean-Pierre Gotteland, El...> ;Lancet. 2022 Sep 17
5 citations
Review of menopausal hormone therapy with estradiol and progesterone versus other estrogens and progestins.
Shelli Graham, David F Archer, James A Simon, Kathleen M Ohleth, Brian Bernick> ;Gynecological Endocrinology. 2022 Nov 1
2 citations
Continuation rates of two different-sized copper intrauterine devices among nulliparous women: Interim 12-month results of a single-blind, randomised, multicentre trial.
David Hubacher, Courtney A Schreiber, David K Turok, Jeffrey T Jensen, Mitchell D Creinin, Kavita Nanda, Katharine O'Connell White, Ila Dayananda, Stephanie B Teal, Pa...> ;Eclinicalmedicine. 2022 Sep 1
5 citations
Bleeding Patterns of Oral Contraceptives with a Cyclic Dosing Regimen: An Overview.
David F Archer, Diana Mansour, Jean-Michel Foidart> ;Journal of Clinical Medicine. 2022 Aug 8
3 citations
Evaluation of ovulation and safety outcomes in a multi-center randomized trial of three 84 day ulipristal acetate regimens.
Carolyn L Westhoff, David F Archer, Kurt Barnhart, Philip Darney, Melissa Gilliam, Jeffrey Jensen, Anita Nelson, Stephanie Teal, Michael Thomas, Jack Hu, Jill Brown, D...> ;Contraception. 2022 Aug 1
The Plasminogen Activator System, Glucocorticoid, and Mineralocorticoid Receptors in the Primate Endometrium During Artificial Menstrual Cycles
Esra Demirel, Reem Sabouni, Neelima Chandra, Ov D. Slayden, David F. Archer> ;Reproductive Sciences. 2021 Nov 18
3 citations
Reduction of Heavy Menstrual Bleeding in Women Not Designated as Responders to Elagolix Plus Add Back Therapy for Uterine Fibroids.
Elizabeth A. Stewart, David F. Archer, Charlotte D. Owens, Kurt T. Barnhart, Linda D. Bradley, Eve C. Feinberg, Veronica Gillispie-Bell, Anthony N. Imudia, Ran Liu, Ji...> ;Journal of Women's Health. 2021 Sep 28
4 citations
Evaluation of endometrial progesterone receptor expression after 12 weeks of exposure to a low-dose vaginal estradiol insert.
Sebastian Mirkin, James A. Simon, James H. Liu, David F. Archer, Patricia Castro, Shelli Graham, Brian Bernick, Barry S. Komm> ;Menopause. 2021 Jun 1
7 citations
Efficacy and safety of elagolix with add-back therapy in women with uterine fibroids and coexisting adenomyosis
Ozgul Muneyyirci-Delale, David F. Archer, Charlotte D. Owens, Kurt T. Barnhart, Linda D. Bradley, Eve C. Feinberg, Veronica Gillispie, Sandra Hurtado, Jin Hee Kim, Ali...> ;F&S Reports. 2021 May 26
24 citations
Estetrol-drospirenone combination oral contraceptive: North American phase 3 efficacy and safety results
Mitchell D. Creinin, Carolyn Westhoff, Céline Bouchard, Melissa J. Chen, Jeffrey T. Jensen, Sharon L. Achilles, Jean-Michel Foidart, David F. Archer> ;Contraception. 2021 May 15
17 citations
A core outcome set for genitourinary symptoms associated with menopause: the COMMA (Core Outcomes in Menopause) global initiative.
Sarah Lensen, Robin J Bell, Janet S Carpenter, Monica Christmas, Susan R Davis, Karen Giblin, Steven R Goldstein, Tim Hillard, Myra S Hunter, Stamatina Iliodromiti, Un...> ;Menopause. 2021 May 10
19 citations
A core outcome set for vasomotor symptoms associated with menopause: the COMMA (Core Outcomes in Menopause) global initiative.
Sarah Lensen, David Archer, Robin J Bell, Janet S Carpenter, Monica Christmas, Susan R Davis, Karen Giblin, Steven R Goldstein, Tim Hillard, Myra S Hunter, Stamatina I...> ;Menopause. 2021 Apr 26
2 citations
Segesterone acetate serum levels with a regression model of continuous use of the segesterone acetate/ethinyl estradiol contraceptive vaginal system
James H. Liu, Marlena Gehret Plagianos, David F. Archer, James A. Simon, Shelli Graham, Brian Bernick, Sebastian Mirkin> ;Contraception. 2021 Mar 27
1 citations
Drospirenone Effects on the Plasminogen Activator System in Immortalized Human Endometrial Endothelial Cells
Reem Sabouni, David F. Archer, Terry A. Jacot> ;Reproductive Sciences. 2021 Feb 8
4 citations
Endometriosis-Related Pain Reduction During Bleeding and Nonbleeding Days in Women Treated with Elagolix.
Sanjay K. Agarwal, Sukhbir S. Singh, David F. Archer, Yabing Mai, Kristof Chwalisz, Keith Gordon, Eric S. Surrey> ;Journal of Pain Research. 2021 Feb 2
14 citations
Predictors of response for elagolix with add-back therapy in women with heavy menstrual bleeding associated with uterine fibroids
Ayman Al-Hendy, Linda D. Bradley, Charlotte D. Owens, Hui Wang, Kurt T. Barnhart, Eve C. Feinberg, William D. Schlaff, Elizabeth E. Puscheck, Alice Wang, Veronica Gill...> ;American Journal of Obstetrics and Gynecology. 2021 Jan 1
6 citations
Elagolix in the treatment of endometriosis: impact beyond pain symptoms.
David F. Archer, Ahmed M. Soliman, Sanjay K. Agarwal, Hugh S. Taylor> ;Therapeutic Advances in Reproductive Health. 2020 Dec 1
Corrigendum to "Dose-finding study of a 90-day contraceptive vaginal ring releasing estradiol and segesterone acetate" [Contraception 102(3) (2020) 168-173].
Melissa J. Chen, Mitchell D. Creinin, David K. Turok, David F. Archer, Kurt T. Barnhart, Carolyn Westhoff, Michael A. Thomas, Jeffrey T. Jensen, Bruce Variano, Regine ...> ;Contraception. 2020 Dec 1
5 citations
Uterine bleeding with hormone therapies in menopausal women: a systematic review.
James H. Pickar, David F. Archer, Steven R. Goldstein, Risa Kagan, Brian Bernick, Sebastian Mirkin> ;Climacteric. 2020 Sep 7
Join now to see all

Press Mentions

First Approved Vaginal Contraceptive Ring for Year-Long Use Annovera Is Proven EffectiveMarch 26th, 2019
TherapeuticsMD Presents Positive Phase 3 Data in Two Presentations for TX-001HR at ENDO 2017April 3rd, 2017
TherapeuticsMD Presents Detailed Results from Phase 3 Rejoice Trial in Postmenopausal Women with Vulvar and Vaginal Atrophy (VVA) at ENDO 2016April 2nd, 2016

Grant Support

Doxycycline For Bleeding In Progestin Only ContraceptorsEunice Kennedy Shriver National Institute Of Child Health &Human Development2002–2006

Professional Memberships

American College of Obstetricians and Gynecologists
Fellow

Hospital Affiliations

Sentara Norfolk General HospitalNorfolk, Virginia